-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
ZyVersa Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2024.
- ZyVersa Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.75M, a 96.8% increase year-over-year.
- ZyVersa Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$22.4M, a 75.8% increase year-over-year.
- ZyVersa Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$108M, a 728% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)